American Journal of Cardiovascular Disease Research
ISSN (Print): ISSN Pending ISSN (Online): ISSN Pending Website: Editor-in-chief: Dario Galante
Open Access
Journal Browser
American Journal of Cardiovascular Disease Research. 2014, 2(1), 4-8
DOI: 10.12691/ajcdr-2-1-2
Open AccessArticle

Anemia Prevalence and Sociodemographic Factors among Patient with Cardiovascular Disease in Gaza-Palestine

Amal Jamee1, and Yehia Abed2

1AL Shifa Hospital, Cardiology department, Gaza, Palestine

2Al Quds University, Faculty of Public Health, Gaza, Palestine

Pub. Date: January 13, 2014

Cite this paper:
Amal Jamee and Yehia Abed. Anemia Prevalence and Sociodemographic Factors among Patient with Cardiovascular Disease in Gaza-Palestine. American Journal of Cardiovascular Disease Research. 2014; 2(1):4-8. doi: 10.12691/ajcdr-2-1-2


Chronic anemia is a risk factor for cardiovascular diseases outcome in patients with heart failure, dilated cardiomyopathy and uncontrolled hypertension. This study was performed to analyze the prevalence of anemia among cardiac patients and to determine the relationship between anemia and socio demographic characteristics. The study design is a cross sectional based on 300 cardiac patients ( ≥ 19 years) who were hospitalized in ALShifa hospital (Gaza) for 3 months period during the year 2012. The analysis includes socio demographic data, traditional risk factors for cardiovascular diseases (CVD), and Laboratory test included (hemoglobin and clearance creatinine measurement). Collected data was analyzed by using statistical package for social science version 20.0. Anemia was defined as Hemoglobin less than < 12 g/dl in female and less than 13 g/dl in male based on World health organization criteria. Among 300 patients, 181patients (60.3%) were anemic and 119 (39.7%) were non-anemic. The mean age for all population was 61.4 years. Mean age of patients with anemia tends to be higher (63.9 years) than non-anemic (57.7 years) and the differences between the two means reached statistical significant level (P value < 0.001). Anemia was more common in female (71.4%), older age (71.1%), diabetics (70%), impaired clearance creatinine (70%), hypertensive’s (65%) and low education level (64.5%). The highest proportion belonged to valvular heart disease (77.8%), congestive heart failure (74.6%) followed by hypertension (54%), and the lowest is coronary artery disease (46%). Logistic regression reveals that low education, low clearance creatinine level, smoking and diabetes are independently associated with anemia. We conclude that Anemia is common among cardiovascular disease patients, and worsens the prognosis of their clinical condition. Intervention policies to minimize anemia risk factors are needed.

anemia cardiovascular diseases socio demographic factors Gaza Palestine

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  World Health Organization. Proceedings of the 15th Annual Conference of the Indian Society of Hypertension and 4th International CME on Atherosclerosis, “Hypertension and Coronary Artery Disease,” WHO New Delhi India, November. 2005.
[2]  UNRWA United Nations Relief and Work Agency for “Palestine Refugees in the Near East,” Annual Report of the Department of Health. 2006.
[3]  Joyce A, Wahr, “Anemia and Cardiovascular Disease,” Transfusion alternative in transfusion medicine, (2). 24-30. 2008.
[4]  Fauci A, Braunwald E, Kasper D, Hauser S, Longo D, Jameson J, et al. Harrison, “Principle’s of internal medicine,” 17 Ed. New York: McGraw publishing Co. 2008.
[5]  Mark J, Sarnak, Hocine Tighiouart, Guruprasad Manjunath, et al, “Anemia as a Risk Factor for Cardiovascular Disease in the Atherosclerosis Risk in Communities (ARIC) Study,” J Am Coll cardiology, 40 (1). 27-33. 2002.
[6]  Chaves PH, Semba RD, Leng SX, Woodman RC, Ferrucci L, Guralnik JM, Fried LP, “Impact of Anemia and Cardiovascular Disease on Frailty Status of Community-Dwelling Older Women: The Women's Health and Aging Studies II and I,” Journals of Gerontology Series A: Biological Sciences & Medical, 60 (6). 729-735. 2005.
[7]  Patel KV, “Epidemiology of anemia in older adults,” Seminars in Hematology, 45 (4). 210-217. 2008.
[8]  DeMaria R, Ripamonti V, Sandri R, et al ,“The negative prognostic synergism of anemia and heart disease in female nursing home residents,” Am J Cardiol, 96 (10). 1460-1462. 2005.
[9]  Komajda M, “Prevalence of anemia in patients with chronic heart failure and their clinical characteristics,” J Cardiac Failure, 10. 1-4. 2004.
[10]  Ble A, Fink JC, Woodman RC, Klausner MA, Windham BG, Guralnik TM, et al, “Renal function, erythropoietin and anemia of older persons: the In Chianti Study,” Arch Intern Med, 165. 2222-2227. 2005.
[11]  Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC, “Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia,” Blood, 104 (8). 2263-2268. 2004.
[12]  Salive ME, Cornoni-Huntley J, Guralnik JM, Phillips CL, Wallace RB, Ostfeld AM, et al., “Anemia and hemoglobin levels in older persons: relationship with age, gender, and health status,” J Am Geriatr Soc, 40. 489-496. 1992.
[13]  Azin Alizadehasl, Zahra Golmohammadi, Lale Panjavi, Siamak Mahmoodmoradi, Rasoul Azarfarin, “The incidence of anemia in adult patients with cardiovascular diseases in northwest Iran,” Cardiovascular Research Centre, 61 (11). 1091-1095. 2011.
[14]  Raed Odeh, M.B. Bdeir, Tara Conboy, “Prevalence of anemia in a Saudi population with chronic heart failure,” Journal of the Saudi Heart Association, 24 (4). 277-278. 2012.
[15]  Varat MA, Adolph RJ, Fowler NO, “Cardiovascular effects of anemia,” Am Heart Journal, 83 (3). 415-426. 1972.
[16]  Gerry JL, Baird MG, Fortuin NJ, “Evaluation of left ventricular Function in patients with sickle cell anemia,” Am J Med, 60 (7). 968-972. 1976.
[17]  Riva E, Tettamanti M, Mosconi P, Apolone G, Gandini F, Nobili A, et al, “Association of mild anemia with hospitalization and mortality in the elderly: the Health and Anemia population-based study,” Haematologica, 94 (1). 22-28. 2009.
[18]  Hegde N, Rich MW, Gayomali C, “The cardiomyopathy of iron deficiency,” Text Heart Inst Journal, 33 (3). 340-344. 2006.
[19]  Anand IS, Chandrashekhar Y, Ferrari R, et al, “Pathogenesis of oedema in chronic severe anemia: studies of body water and sodium renal function, hemodynamic variables, and plasma hormones,” Br Heart Journal, 70 (4). 357-362. 1993.
[20]  Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, et al, “Predictors of mortality and morbidity in patients with Chronic heart failure,” Eur Heart Journal, 27 (1). 65-75. 2006.
[21]  Velavan P, Khan NK, Goode K, Rigby AS, Loh PH, Komajda M, et al, “Predictors of short term mortality in heart failure-insights from the Euro Heart Failure survey,” Int J Cardiol, 138 (1). 63-69. 2010.
[22]  Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, et al, “Anemia and mortality in heart failure patients a systematic review and meta-analysis,” J Am Coll Cardiol, 52 (10). 818-827. 2008.
[23]  Silverberg DS, Wexler D, Iaina A, “The importance of anemia and its correction in the management of severe congestive heart failure,” Eur J Heart Failure, 4. 681-686. 2002.
[24]  Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, et al, “Predictors of mortality and morbidity in patients with chronic heart failure,” Eur Heart J, 27. 65-75. 2006.
[25]  Velavan P, Khan NK, Goode K, Rigby AS, Loh PH, Komajda M, et al, “Predictors of short term mortality in heart failure-insights from the Euro Heart Failure survey,” Int J Cardiol, 138: 63-69. 2010.
[26]  Salisbury AC, Kosiborod M, “Outcomes associated with anemia in patients with heart failure,” Heart Fail Clin, 6. 359-372. 2010.
[27]  Silverberg DS, Wexler D, Iaina A, and Schwartz D, “The role of correction of anemia in patients with congestive heart failure: a short review,” Eur J Heart Fail, 10 (9). 819-823. 2008.
[28]  Adams KF, Patterson JH, Oren RM, Mehra MR, O'Connor CM, Pina IL, et al, “Prospective assessment of the occurrence of anemia in patients with heart Failure: results from the Study of Anemia in a Heart Failure Population, STAMINA-HFP Registry,” Am Heart J, 157 (5). 926-932. 2009.
[29]  daSilveira AD, Ribeiro RA, Rossini AP, Stella SF, Ritta HA, Stein R, et al, “Association of anemia with clinical outcomes in stable coronary artery disease,” Coron Artery Disease, 19 (1). 21-26. 2008.
[30]  Bassand JP, Hamm WC, Ardissino D, Boersma E, Budaj A, Ferna´ ndez-Aviles F, et al, “Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes,” Eur HeartJ, 28. 1598-1660. 2007.
[31]  Bassand JP, Hamm WC, Ardissino D, Boersma E, Budaj A, Ferna´ ndez-Avile F, et al, “Guıa de Practica Clınica para el diagnostico y tratamiento del sındrome coronario agudo sin elevacion del segmento ST,” Rev Esp Cardiol, 60. 1070-1080. 2007.
[32]  Gonzalez-Ferrer JJ, Garcıa-Rubira JC, Vivas-Balcones D, Nunez-Gil I, Carda Barrio R, Fuentes-Ferrer M, et al, “[ Pronostico intrahospitalario de la hemoglobina en pacientes con sındrome coronario agudo,” Rev ESP Cardiol,; 61. 945-952. 2008.
[33]  Oona M, Merce C, Lluis R, “In-hospital Acquired Anemia in Acute Coronary Syndrome. Predictors, In-hospital Prognosis and One-year Mortality,” Rev Esp Cardiol, 65 (8). 742-748. 2012.
[34]  Salisbury AC, Amin AP, Reid KJ, Wang TY, Masoudi FA, Chan PS, et al, “Hospital acquired anemia and in-hospital mortality in patients with acute myocardial Infarction,” Am Heart J, 162. 300-309. 2011.
[35]  Salisbury AC, Alexander KP, Reid KJ, Masoudi FA, Rathore SS, Wang TY, et al, “Incidence, correlates and outcomes of acute, hospital-acquired anemia in Patients with acute myocardial infarction,” Circ Cardiovascular Qual Outcomes, 3. 337-346. 2010.
[36]  Shaffer C, “Diagnostic blood loss in mechanically ventilated patients,” Heart Lung, 36. 217-222. 2007.
[37]  Thavendiranathan P, Bagai A, Ebidia A, Detsky AS, Choudhry NK, “Do blood tests cause anemia in hospitalized patients? The effect of diagnostics phlebotomy on hemoglobin and hematocrit levels,” J Gen Intern Med, 20. 520-524. 2005.
[38]  James S, Oldgren J, Lindback J, Johnston N, Siegbahn A, Wallentin L 2005 An acute Inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease,” Am Heart J, 149. 619-626. 2005.
[39]  Sa´nchez PL, Morinigo JL, Pabo´n P, Martı´n F, Piedra I, Palacios IF, et al, “Prognostic relations between inflammatory markers and mortality in diabetic patients With non-ST elevation acute coronary syndrome,”. Heart, 264-269. 2004.
[40]  Mueller C, Buettner HJ, Hodgson JM, Marsch S, Perruchoud AP, et al, “Inflammation and long-term mortality after non-ST elevation acute Coronary syndrome treated with a very early invasive strategy in 1042 consecutive Patients,” Circulation, 105. 1412-1415. 2002.
[41]  Hasan F, O'Brien CS, Sanyal A, Dalton HR, “Aortic stenosis and gastrointestinal bleeding,” J R Soc Med, 97 (2). 81-82. 2004.
[42]  Maria M, Alexandros P, Fragiskos P, Evangelos Z, DimitrisA, George K, Gregory C, Panos V, “Systemic blood pressure profile in hypertensive patients with low hemoglobin concentrations,” International Journal of Cardiology, 142 (1). 95-96. 2010.
[43]  Paul B, Wilfred NC, Woodman R, Depasquale C, “Prevalence and correlates of anemia in essential hypertension,” Clin Exp Pharmacol Physiol, 35 (12). 1461-1464. 2008.